Sabre Insurance Group PLC Exercise of Overallotment Option (2919Z)

TIDMSBRE

RNS Number : 2919Z

Sabre Insurance Group PLC

13 December 2017

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT

For Immediate Release

13 December 2017

SABRE INSURANCE GROUP PLC

Exercise of Overallotment Option

Further to its announcement on 6 December 2017 relating to its initial public offering (the "Offer"), Sabre Insurance Group plc (the "Company") confirms that Barclays Bank PLC, as stabilisation manager, has exercised in its entirety the over-allotment option granted by BC European Capital IX, a private equity fund advised by BC Partners LLP ("BC European Capital"), in respect of 12,500,000 ordinary shares of GBP0.001 ("Ordinary Shares") each in the capital of the Company (the "Over-allotment Shares"), taking the total number of Ordinary Shares that were subject to the Offer to 137,500,000. The Over-allotment Shares will be sold at the offer price of 230 pence per Ordinary Share.

Following the Offer and the exercise of the over-allotment option, BC European Capital will hold 72,619,567 Ordinary Shares being equal to 29.0 per cent. of the total issued share capital of the Company.

Enquiries

 
 Evercore Partners International LLP 
  Financial Adviser to the Company 
  Mark Hennessy 
  Jim Renwick                                        [phone] 
 Tulchan Communications 
  Financial Communications Adviser to the Company 
  James Macey White 
  Michelle Clarke                                    [phone] 
 

Ticker: SBRE

SEDOL: BYWVDP4

ISIN: GB00BYWVDP49

LEI: 2138006RXRQ8P8VKGV98

Important Notice

This announcement does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase, any securities in the United States of America, Australia, Canada, Japan or South Africa or in any jurisdiction in which such offer or solicitation is unlawful.

Neither this announcement nor any copy of it may be made or transmitted into the United States of America, or distributed, directly or indirectly, in the United States of America. Neither this announcement nor any copy of it may be taken or transmitted directly or indirectly into Australia, Canada, Japan or South Africa or to any persons in any of those jurisdictions, except in compliance with applicable securities laws. Any failure to comply with this restriction may constitute a violation of United States, Australian, Canadian, Japanese or South African securities laws. The distribution of this announcement in other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions.

The securities referred to herein have not been, and will not be, registered under the US Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any state or other jurisdiction of the United States of America and may not be offered or sold in the United States of America except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with such other applicable laws. There will be no public offering of the securities in the United States of America. The securities referred to herein have not been registered under the applicable securities laws of, Canada, Australia, Japan or South Africa and, subject to certain exceptions, may not be offered or sold within Canada, Australia, Japan or South Africa or to any national, resident or citizen of Canada, Australia, Japan or South Africa.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCUOSBRBUAUAAA

(END) Dow Jones Newswires

December 13, 2017 12:44 ET (17:44 GMT)